SMOFKABIVEN amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 1970 mL Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

smofkabiven amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 1970 ml

fresenius kabi australia pty ltd - fish oil - rich in omega-3 acids, quantity: 30 g/l; soya oil, quantity: 60 g/l; olive oil, quantity: 50 g/l; medium chain triglycerides, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; sodium oleate; egg lecithin; glycerol; water for injections; dl-alpha-tocopherol - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.

SMOFKABIVEN amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 1477 mL Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

smofkabiven amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 1477 ml

fresenius kabi australia pty ltd - olive oil, quantity: 50 g/l; fish oil - rich in omega-3 acids, quantity: 30 g/l; medium chain triglycerides, quantity: 60 g/l; soya oil, quantity: 60 g/l - injection, intravenous infusion - excipient ingredients: water for injections; dl-alpha-tocopherol; sodium oleate; sodium hydroxide; egg lecithin; glycerol - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.

SMOFKABIVEN amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 986 mL Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

smofkabiven amino acids 5.1% / lipids 3.8% / glucose 12.7% / electrolytes 0.7% emulsion for intravenous infusion bag 986 ml

fresenius kabi australia pty ltd - medium chain triglycerides, quantity: 60 g/l; soya oil, quantity: 60 g/l; olive oil, quantity: 50 g/l; fish oil - rich in omega-3 acids, quantity: 30 g/l - injection, intravenous infusion - excipient ingredients: sodium oleate; egg lecithin; sodium hydroxide; glycerol; dl-alpha-tocopherol; water for injections - parenteral nutrition for adult patients and paediatric patients aged 2 years and above when oral or enteral nutrition is impossible, insufficient or contraindicated.

PHYSIONEAL 40 Glucose 1.36% w/v Peritoneal Dialysis Solution Bag Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

physioneal 40 glucose 1.36% w/v peritoneal dialysis solution bag

vantive pty ltd - glucose monohydrate, quantity: 15 g/l (equivalent: glucose, qty 13.6 g/l); sodium bicarbonate, quantity: 2.1 g/l; sodium chloride, quantity: 5.38 g/l; magnesium chloride hexahydrate, quantity: 51 mg/l; sodium lactate, quantity: 1.68 g/l; calcium chloride dihydrate, quantity: 0.184 g/l - solution, dialysis - excipient ingredients: water for injections; hydrochloric acid; sodium hydroxide - physioneal 40 is indicated for use in peritoneal dialysis in patients with acute or chronic renal failure.

EXTRANEAL 7.5% w/v icodextrin peritoneal dialysis solution twin bag with drainage bag Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

extraneal 7.5% w/v icodextrin peritoneal dialysis solution twin bag with drainage bag

vantive pty ltd - icodextrin, quantity: 75 g/l; sodium chloride, quantity: 5.4 g/l; sodium lactate, quantity: 4.5 g/l; calcium chloride dihydrate, quantity: 257 mg/l; magnesium chloride hexahydrate, quantity: 51 mg/l - solution, dialysis - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - indicated as "an alternative osmotic agent in dialysis solution for the long dwell exchange in patients treated with peritoneal dialysis."

EXTRANEAL 7.5% w/v icodextrin peritoneal dialysis solution bag Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

extraneal 7.5% w/v icodextrin peritoneal dialysis solution bag

vantive pty ltd - icodextrin, quantity: 75 g/l; sodium chloride, quantity: 5.4 g/l; sodium lactate, quantity: 4.5 g/l; calcium chloride dihydrate, quantity: 257 mg/l; magnesium chloride hexahydrate, quantity: 51 mg/l - solution, dialysis - excipient ingredients: water for injections; sodium hydroxide; hydrochloric acid - indicated as "an alternative osmotic agent in dialysis solution for the long dwell exchange in patients treated with peritoneal dialysis."

DOBUTAMINE SANDOZ dobutamine 250mg/20mL (as hydrochloride) injection ampoule Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

dobutamine sandoz dobutamine 250mg/20ml (as hydrochloride) injection ampoule

sandoz pty ltd - dobutamine hydrochloride, quantity: 14 mg/ml (equivalent: dobutamine, qty 12.5 mg/ml) - injection, concentrated - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections; sodium metabisulfite - adults who require short-term treatment of cardiac failure secondary to acute myocardial infarction, or cardiac surgery.

HEXVIX hexaminolevulinate (as hydrochloride) 85 mg powder for intravesical solution vial plus diluent vial Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

hexvix hexaminolevulinate (as hydrochloride) 85 mg powder for intravesical solution vial plus diluent vial

endotherapeutics pty ltd - hexaminolevulinate hydrochloride, quantity: 100 mg (equivalent: hexaminolevulinate, qty 85 mg) - diluent, not applicable - excipient ingredients: sodium hydroxide; dibasic sodium phosphate dihydrate; monobasic potassium phosphate; sodium chloride; water for injections; hydrochloric acid - this medicinal product is for diagnostic use only.,hexvix blue light fluorescence cystoscopy is indicated as adjunct to standard white light cystoscopy to contribute to the diagnosis and management of bladder cancer in patients with known or high suspicion of bladder cancer.

ONDANSETRON ACCORD ondansetron (as hydrochloride dihydrate) 4 mg/2 mL solution for injection pre-filled syringe Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

ondansetron accord ondansetron (as hydrochloride dihydrate) 4 mg/2 ml solution for injection pre-filled syringe

accord healthcare pty ltd - ondansetron hydrochloride dihydrate, quantity: 4.99 mg (equivalent: ondansetron, qty 4 mg) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; citric acid monohydrate; sodium citrate dihydrate; hydrochloric acid; sodium chloride - ondansetron injection is indicated ? for the prevention and treatment of nausea and vomiting induced by cytotoxic therapy and radiotherapy. ? for the prevention and treatment of post-operative nausea and vomiting.

Compound Sodium Lactate (Hartmanns) New Zealand - Ingliż - Medsafe (Medicines Safety Authority)

compound sodium lactate (hartmanns)

fresenius kabi new zealand limited - calcium chloride dihydrate 0.27 g;  ;  ;  ;  ; potassium chloride 0.4 g;  ;  ;  ; sodium chloride 6 g;  ;  ;  ;  ;  ; sodium lactate 3.17 g (as 6.34g sodium lactate solution 50%);   - solution for infusion - active: calcium chloride dihydrate 0.27 g         potassium chloride 0.4 g       sodium chloride 6 g           sodium lactate 3.17 g (as 6.34g sodium lactate solution 50%)   excipient: hydrochloric acid sodium hydroxide water for injection - compound sodium lactate (hartmann's) is used for intravenous fluid and electrolyte replacement.